582
Views
5
CrossRef citations to date
0
Altmetric
Author's View

Thwarting galectin-induced immunosuppression in breast cancer

, &
Article: e24077 | Received 18 Feb 2013, Accepted 21 Feb 2013, Published online: 01 May 2013

References

  • Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331:1565 - 70; http://dx.doi.org/10.1126/science.1203486; PMID: 21436444
  • Heckel MC, Wolfson A, Slachta CA, Schwarting R, Salgame P, Katsetos CD, et al. Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70. Cell Immunol 2011; 266:143 - 53; http://dx.doi.org/10.1016/j.cellimm.2010.09.010; PMID: 21055733
  • Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 2007; 28:1067 - 73; http://dx.doi.org/10.1093/carcin/bgl250; PMID: 17183065
  • Bilski A, Pasz-Walczak G, Kubiak R, Sek P, Chalubinska J, Fendler W, et al. TRAIL protein expression in breast cancer cells correlates with nuclear grade. Arch Med Sci 2010; 6:545 - 51; http://dx.doi.org/10.5114/aoms.2010.14466; PMID: 22371798
  • Coussens LM, Pollard JW. Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol 2011; 3:3; http://dx.doi.org/10.1101/cshperspect.a003285; PMID: 21123394
  • Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?. Cell Immunol 2011; 266:116 - 22; http://dx.doi.org/10.1016/j.cellimm.2010.09.005; PMID: 20970781
  • Rabinovich GA, Croci DO. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 2012; 36:322 - 35; http://dx.doi.org/10.1016/j.immuni.2012.03.004; PMID: 22444630
  • Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, et al. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma. J Exp Med 2012; 209:1985 - 2000; http://dx.doi.org/10.1084/jem.20111665; PMID: 23027923
  • Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan-Dylon S, Méndez-Huergo SP, et al. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res 2013; 73:1107 - 17; http://dx.doi.org/10.1158/0008-5472.CAN-12-2418; PMID: 23204230
  • Chuck MI, Zhu M, Shen S, Zhang W. The role of the LAT-PLC-gamma1 interaction in T regulatory cell function. J Immunol 2010; 184:2476 - 86; http://dx.doi.org/10.4049/jimmunol.0902876; PMID: 20130215